International Cancer Research Conference
March 24-26, 2025 | Singapore
Cancer Detection and Diagnosis
Early cancer detection is a public and policy priority, with primary care being the perfect setting to do so. This has sparked a desire for better cancer early detection tests, preferably ones that can be used in primary care settings. After the detection of a malignant cancer, a precise diagnosis and stage of the disease are required for the development of a treatment strategy. Whether it’s the early diagnosis of a cancer or the detection of a recurrence, cancer detection & diagnosis entails detecting the prevalence of cancer in the body and determining the extent of disease. For some cancers, this definition can be broadened to encompass detecting precancerous lesions that are likely to progress to cancer, allowing for early intervention and even preventing cancer.
- Biopsy
- Endoscopic examination
- Genetic tests
- Diagnostic Imaging
- Tumor markers
Patricia Tai
Saskatchewan Cancer Agency, Canada
Rajvir Dahiya
University of California San Francisco, United States
Michael Thompson
University of Toronto, Canada
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Andrea González Báez
Autonomous University of Nuevo Leon, Mexico
Qian Zhang
The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, China
Zheng Wang
Shanghai Jiao Tong University School of Medicine, ChinaSubmit your abstract Today
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Hospital care for cancer patients - safety, quality of care, education and respect for patient’s rights
Mariola Wioletta Borowska, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Title : Importin7 induces M2 macrophage and promotes the progress of colorectal cancer by regulating the nucleus translocation of GRP78
Changjiang Yang, Peking University People's Hospital, China
Title : Cancer-associated fibroblasts derived soluble CADM1 predicts response to neoadjuvant chemoimmunotherapy in lung cancer
Jian Li, Shanghai Jiaotong University, China